LFCR — Lifecore Biomedical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Lifecore Biomedical, fiscal year end - May 26th, USD millions except per share, conversion factor applied.

	2020 May 31st	2021 May 30th	R2022 May 29th	2023 May 28th	2024 May 26th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.36	1.29	0.991	19.1	8.46
Net Total Accounts Receivable
Net Total Receivables	76.2	70	38.3	29	31.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	157	148	117	93.9	81
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	218	200	124	139	151
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	541	503	275	254	254
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	164	102	177	39.3	38.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	310	300	187	218	200
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	231	203	87.8	35.1	53.9
Total Liabilities & Shareholders' Equity	541	503	275	254	254
Total Common Shares Outstanding
Total Preferred Shares Outstanding